A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma

Conditions:   Alveolar Soft Part Sarcoma;   Leiomyosarcoma;   Synovial Sarcoma;   Soft-Tissue Sarcoma Interventions:   Drug: AL 3818;   Drug: Dacarbazine Sponsor:   Advenchen Laboratories, LLC Not yet recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials